News
anti-VEGF
New anti-VEGF therapy shows promise in Phase 1 Clinical trial
The new drug is manufactured by 4D Molecular Therapeutics and is a dual-transgene intravitreal gene therapy.
AMD
One neovascular AMD treatment more effective than the other
A recent study reveals that one anti-VEGF treatment is more effective than another commonly used treatment.
AMD
Eye implant to treat wet macular degeneration approved by FDA
The device is the size of a grain of rice and is refilled every six months.
age-related macular degeneration
Study indicates some patients may be "weaned" off injections for wet macular degeneration
Study results offer hope to patients with wet macular degeneration who are receiving anti-VEGF injections.
age-related macular degeneration
Gene Therapy for Macular Degeneration positive results
For patients suffering from age-related macular degeneration, gene therapy has the potential to transfigure the treatment options that are available.
age-related macular degeneration
New Anti-VEGF treatment has positive results in first clinical trial
EyePoint Pharmaceuticals recently announced results of the Phase 1 clinical trial of their new wet age-related macular degeneration treatment, EYP-1901.
age-related macular degeneration
Port Delivery System therapy looking for FDA approval
The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.
age-related macular degeneration
5 Eye Diseases that can lead to Blindness
There are five eye diseases that are the leading causes of blindness and low vision in the United States: age-related macular degeneration, cataracts, glaucoma, diabetic retinopathy and eye injurie...
AMD
Parkinson's drug may be a treatment for advanced age-related macular degeneration
Researchers discovered that levodopa is safe, well-tolerated and not only improved visual outcomes but also delayed anti-VEGF injections.